Birdwatch Archive

Birdwatch Note

2023-10-02 16:35:57 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

Allogene Therapeutics was at $21.73 on Jan. 31, 2020 but doubled during Covid to $54 in May 2020. It stayed above $22 until August 2021, 1.5 years later. Selling the "stock just weeks before the coronavirus pandemic " could have caused investors to miss significant gains. https://finance.yahoo.com/quote/ALLO?p=ALLO&.tsrc=fin-srch

Written by A746C72C6317CDADD143DBB72957EA8FEBD48B6B0B617C9EB80CD37A48A44240
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1708857382770724876

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1708883527297651180
  • noteId - 1708883527297651180
  • participantId -
  • noteAuthorParticipantId - A746C72C6317CDADD143DBB72957EA8FEBD48B6B0B617C9EB80CD37A48A44240 Participant Details
  • createdAtMillis - 1696264557087
  • tweetId - 1708857382770724876
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 0
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • Allogene Therapeutics was at $21.73 on Jan. 31, 2020 but doubled during Covid to $54 in May 2020. It stayed above $22 until August 2021, 1.5 years later. Selling the "stock just weeks before the coronavirus pandemic " could have caused investors to miss significant gains. https://finance.yahoo.com/quote/ALLO?p=ALLO&.tsrc=fin-srch

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2023-10-02 16:35:57 UTC
(1696264557087)
1969-12-31 23:59:59 UTC
(-1)
2023-10-03 02:49:27 UTC
(1696301367088)
NEEDS_MORE_RATINGS 1969-12-31 23:59:59 UTC
(-1)

Note Ratings

rated at rated by
2023-10-02 17:31:23 -0500 Rating Details
2023-10-02 17:27:57 -0500 Rating Details
2023-10-02 16:38:13 -0500 Rating Details
2023-10-02 16:00:00 -0500 Rating Details
2023-10-02 15:14:20 -0500 Rating Details
2023-10-02 14:26:00 -0500 Rating Details
2023-10-02 14:25:59 -0500 Rating Details
2023-10-02 14:05:44 -0500 Rating Details
2023-10-02 14:01:58 -0500 Rating Details
2023-10-02 13:58:27 -0500 Rating Details
2023-10-02 13:39:04 -0500 Rating Details
2023-10-02 13:35:05 -0500 Rating Details
2023-10-02 12:53:54 -0500 Rating Details
2023-10-02 12:44:29 -0500 Rating Details
2023-10-02 12:07:26 -0500 Rating Details
2023-10-02 12:02:13 -0500 Rating Details
2023-10-02 11:58:59 -0500 Rating Details
2023-10-02 11:43:50 -0500 Rating Details
2023-10-02 11:43:46 -0500 Rating Details
2023-10-02 11:41:34 -0500 Rating Details
2023-10-02 11:38:42 -0500 Rating Details
2023-10-02 11:37:50 -0500 Rating Details
2023-10-03 08:48:36 -0500 Rating Details
2023-10-03 07:46:07 -0500 Rating Details
2023-10-02 20:21:11 -0500 Rating Details
2023-10-04 07:58:19 -0500 Rating Details